Cartesian Therapeutics Inc. (NASDAQ: RNAC)
$17.96
+0.0400 ( +0.22% ) 154.3K
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Market Data
Open
$17.96
Previous close
$17.92
Volume
154.3K
Market cap
$384.83M
Day range
$17.88 - $18.79
52 week range
$11.67 - $41.87
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 5 | Apr 19, 2024 |
4 | Insider transactions | 1 | Apr 10, 2024 |
4 | Insider transactions | 1 | Apr 10, 2024 |
4 | Insider transactions | 3 | Apr 10, 2024 |
4 | Insider transactions | 1 | Apr 10, 2024 |
4 | Insider transactions | 1 | Apr 10, 2024 |
4 | Insider transactions | 1 | Apr 10, 2024 |
4 | Insider transactions | 1 | Apr 10, 2024 |
8-k | 8K-related | 40 | Apr 09, 2024 |
8-k | 8K-related | 15 | Apr 01, 2024 |